Source: GlobalNewswire

Press Release: Lungpacer : Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation

Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation

Read full article »
Lungpacer's Competitors | Lungpacer's News | Lungpacer's Financials
Stay up-to-date with the latest news on Lungpacer
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Doug Evans's photo - President & CEO of Lungpacer

President & CEO

Doug Evans

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Lungpacer